GALECTIN THERAPEUTICS INC (GALT)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$20.09M | -$42.43M | -$38.07M | -$38.35M | -$30.18M | -$23.44M | -$13.44M | -$13.60M | -$16.25M | -$21.48M |
| Net Income | -$30.84M | -$47.05M | -$41.07M | -$38.78M | -$30.53M | -$23.46M | -$13.29M | -$13.90M | -$16.23M | -$21.44M |
| EPS (Diluted) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | — | — | — | — |
| Total Assets | $19.53M | $17.50M | $28.20M | $21.29M | $41.83M | $29.60M | $48.47M | $9.01M | $4.16M | $15.79M |
| Total Liabilities | $145.73M | $120.56M | $88.44M | $53.48M | $39.21M | $5.41M | $2.87M | $2.11M | $2.97M | $3.78M |
| Shareholders' Equity | -$127.92M | -$104.79M | -$61.96M | -$33.92M | $893.0K | $22.47M | $43.87M | $5.17M | -$530.0K | $10.29M |
| Cash & Equivalents | $17.72M | $15.12M | $25.66M | $18.59M | $39.65M | $27.14M | $47.48M | $8.25M | $3.05M | $15.36M |
| Operating Cash Flow | -$23.88M | -$41.77M | -$32.97M | -$31.06M | -$24.31M | -$20.60M | -$10.85M | -$10.18M | -$15.89M | — |
| Shares Outstanding | 65.20M | 63.16M | 61.85M | 59.43M | 59.34M | 57.08M | 56.89M | 41.19M | 35.79M | 32.91M |